PHIO Q2 2018 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$58,000

Gross Profit

-$1M-1939.7% margin

Operating Income

-$2M-3274.1% margin

Net Income

-$2M-3277.6% margin

EPS (Diluted)

$-2755.61

QoQ Revenue Growth

+152.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$37,000

Balance Sheet

Total Assets

$6M

Total Liabilities

$3M

Stockholders' Equity

$3M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58,000	$0	—
Gross Profit	-$1M	-$1M	+15.3%
Operating Income	-$2M	-$3M	+24.5%
Net Income	-$2M	-$3M	+24.4%